Chao Han

Chao Han

Johnson & Johnson Co. - New Jersey / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4392755
-
person_outline Chao Han's MOST POPULAR ARTICLES
1-) Discovery of dabrafenib: a selective inhibitor of Raf kinases with antitumor activity against B-Raf-driven tumors ACS medicinal chemistry letters 4 (3), 358-362, 2013
2-) 3-(1, 1-Dioxo-2 H-(1, 2, 4)-benzothiadiazin-3-yl)-4-hydroxy-2 (1 H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase Journal of medicinal chemistry 49 (3), 971-983, 2006
3-) Abstract B88: A selective Raf kinase inhibitor induces cell death and tumor regression of human cancer cell lines encoding B‐RafV600E mutation Molecular Cancer Therapeutics 8 (12_Supplement), B88-B88, 2009
4-) Preclinical drug metabolism and pharmacokinetic evaluation of GW844520, a novel anti‐malarial mitochondrial electron transport inhibitor Journal of pharmaceutical sciences 95 (12), 2657-2672, 2006
5-) Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptides Drug metabolism and disposition 37 (12), 2375-2382, 2009